LM-PCR permits highly representative whole genome amplification of DNA isolated from small number of cells and paraffin-embedded tumor tissue sections

Diagnostic Molecular Pathology

Volumn 13, Issue 2, 2004, Pages 105-115

  Liu, Dongxin ^a   Liu, Cheng ^a   De Vries, Sandy ^b   Waldman, Frederic ^b   Cote, Richard J ^a   Datar, Ram H ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Comparative genome hybridization; Formalin fixed paraffin embedded tissue sections; Genetic changes; Global genome amplification; Laser captured microdissection; Ligation mediated PCR

Indexed keywords

FORMALDEHYDE; GENOMIC DNA; PARAFFIN;

ARTICLE; CHROMOSOMAL LOCALIZATION; COMPARATIVE GENOMIC HYBRIDIZATION; EMBEDDING; GENE AMPLIFICATION; GENETIC ANALYSIS; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE FIXATION; TISSUE SECTION; TUMOR; TUMOR CELL CULTURE;

CELL LINE, TUMOR; DNA, NEOPLASM; GENOME; HUMANS; MALE; MICRODISSECTION; NUCLEIC ACID HYBRIDIZATION; PARAFFIN EMBEDDING; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2442637752     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200406000-00007     Document Type: Article

References (25)

1. Fearon ER, Vogelstein BA. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.
2. Borst M, Miller DM. DNA isolation and Southern analysis: a clinician's view. Am J Med Sci. 1990;299:356-360.
3. Deng G, Chen LC, Schott DR, et al. Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res. 1994;54:499-505.
4. Hermsen MA, Meijer GA, Baak JP, et al. Comparative genomic hybridization: a new tool in cancer pathology. Hum Pathol. 1996;27:342-349.
5. Mies C. Molecular pathology of paraffin embedded tissues: current clinical applications. Diagn Mol Pathol. 1992;1:206.
6. Mies C. Molecular biological analysis of paraffin-embedded tissues. Hum Pathol. 1994;6:555-560.
7. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science. 1996;274:998-1001.
8. Lucito R, Nakimura M, West JA, et al. Genetic analysis using genomic representations. Proc Natl Acad Sci USA. 1998;95:4487-4492.
9. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, NY, 1989
10. Veltman JA, Fridlyand J, Pejavar S, et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 2003;63:2872-2880.
11. Wilhelm M, Veltman JA, Olshen AB, et al. Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res. 2002;62:957-960.
12. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet. 1998;20:207-211.
13. Esrig D, Spruck CH, Nichols PW, et al. P53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer. Am J Pathol. 1993;143:1389-1397.
14. Markl ID, Jones PA. Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer. Cancer Res. 1998;58:5348-5353.
15. Liu S, Thaler DS, Libchaber A. Signal and noise in bridging PCR. BMC Biotechnol. 2002;2:13-21.
16. Telenius H, Carter NP, Bebb CE, et al. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics. 1992;13:718-725.
17. Xu K, Tang Y, Grifo JA, et al. Primer extension preamplication for detection of multiple genetic loci from single human blastomeres. Hum Reprod. 1993;8:2206-2210.
18. Huang Q, Schantz SP, Rao PH, et al. Improving degenerate oligonucleotide primed PCR-comparative genomic hybridization for analysis of DNA copy number changes in tumors. Genes Chromosom Cancer. 2000;28:395-403.
19. Barbaux S, Poirier O, Cambien F. Use of degenerate oligonucleotide primed PCR (DOP-PCR) for the genotyping of low-concentration DNA samples. J Mol Med. 2001;79:329-332.
20. Hirose Y, Aldape K, Takahashi M, et al. Tissue microdissection and degenerate oligonucleotide primed-polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors. J Mol Diagn. 2001;3:62-67.
21. Larsen J, Ottesen AM, Lundsteen C, et al. Optimization of DOP-PCR amplification of DNA for high-resolution comparative genomic hybridization analysis. Cytometry. 2001;44:317-325.
22. Casas E, Kirkpatrick BW. Evaluation of different amplification protocols for use in primer-extension preamplification. Biotechniques. 1996;20:219-225.
23. Stoecklein NH, Erbersdobler A, Schmidt-Kittler O, et al. SCOMP is superior to degenerated oligonucleotide primed-polymerase chain reaction for global amplification of minute amounts of dna from microdissected archival tissue Samples. Am J Pathol. 2002;161:43-51.
24. Klein CA, Schmidt-Kittler O, Schardt JA, et al. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci U S A. 1999;96:4494-4499.
25. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst. 1999;91:1113-1124.